Y. Futami

Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients

P. Hammerman, Kwok-Kin Wong, G. Dranoff, 2018, JCI insight.

Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles

Y. Inoue, T. Tomonaga, K. Ueda, 2022, International immunology.

CD14 and LBP as Novel Biomarkers for Sarcoidosis by Proteomics of Extracellular Vesicles

Y. Inoue, T. Tomonaga, K. Ueda, 2021 .

Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis.

H. Inohara, D. Okuzaki, A. Kumanogoh, 2020, The Journal of allergy and clinical immunology.

Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres

K. Mizuguchi, Takako Sasaki, T. Tomonaga, 2021, ERJ Open Research.

IL-33 Induces Sema4A Expression in Dendritic Cells and Exerts Antitumor Immunity

D. Ito, D. Okuzaki, A. Kumanogoh, 2021, The Journal of Immunology.

Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer

T. Aoshi, Y. Kato, N. Takemoto, 2024, JCI insight.